Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Kim

Showing results (71-80 of 226) with videos related to

Pageof 23
Sort By:
Pharmacogenetics and Genomics|November 9, 2021
A novel NUDT15 variant identified in Caucasian TPMT wild type patients with inflammatory bowel disease and azathioprine-related myelotoxicityQian Wang, Jaymie Mailloux, Ute I Schwarz, et al.
Pharmaceutics|May 5, 2019
<i>DPYD</i> and Fluorouracil-Based Chemotherapy: Mini Review and Case ReportTheodore J Wigle, Elena V Tsvetkova, Stephen A Welch, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2019
HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel diseaseAze Wilson, Celeste Peel, Qian Wang, et al.
Molecular Pharmacology|March 28, 2013
Transport function and transcriptional regulation of a liver-enriched human organic anion transporting polypeptide 2B1 transcriptional start site variantMichael J Knauer, Anthea J Girdwood, Richard B Kim, et al.
Clinical Pharmacology and Therapeutics|January 25, 2003
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjectsGeorge K Dresser, Ute I Schwarz, Grant R Wilkinson, et al.
Advanced Drug Delivery Reviews|October 31, 2002
CYP2C9 allelic variants: ethnic distribution and functional significanceHong-Guang Xie, Harish C Prasad, Richard B Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activationRommel G Tirona, Brenda F Leake, Allan W Wolkoff, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
Polymorphism screening in the cardiac K+ channel gene KCNA5Chantale Simard, Benoit Drolet, Ping Yang, et al.
Journal of Personalized Medicine|December 14, 2017
Pharmacogenomics Guided-Personalization of Warfarin and TamoxifenTheodore J Wigle, Laura E Jansen, Wendy A Teft, et al.
Molecular Pharmacology|October 26, 2016
Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and ClearanceHannah H Lee, Brenda F Leake, Richard B Kim, et al.
Pageof 23

Showing results (71-80 of 226) with videos related to

Sort By:
Pageof 23
Pharmacogenetics and Genomics|November 9, 2021
A novel NUDT15 variant identified in Caucasian TPMT wild type patients with inflammatory bowel disease and azathioprine-related myelotoxicityQian Wang, Jaymie Mailloux, Ute I Schwarz, et al.
Pharmaceutics|May 5, 2019
<i>DPYD</i> and Fluorouracil-Based Chemotherapy: Mini Review and Case ReportTheodore J Wigle, Elena V Tsvetkova, Stephen A Welch, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2019
HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel diseaseAze Wilson, Celeste Peel, Qian Wang, et al.
Molecular Pharmacology|March 28, 2013
Transport function and transcriptional regulation of a liver-enriched human organic anion transporting polypeptide 2B1 transcriptional start site variantMichael J Knauer, Anthea J Girdwood, Richard B Kim, et al.
Clinical Pharmacology and Therapeutics|January 25, 2003
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjectsGeorge K Dresser, Ute I Schwarz, Grant R Wilkinson, et al.
Advanced Drug Delivery Reviews|October 31, 2002
CYP2C9 allelic variants: ethnic distribution and functional significanceHong-Guang Xie, Harish C Prasad, Richard B Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activationRommel G Tirona, Brenda F Leake, Allan W Wolkoff, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
Polymorphism screening in the cardiac K+ channel gene KCNA5Chantale Simard, Benoit Drolet, Ping Yang, et al.
Journal of Personalized Medicine|December 14, 2017
Pharmacogenomics Guided-Personalization of Warfarin and TamoxifenTheodore J Wigle, Laura E Jansen, Wendy A Teft, et al.
Molecular Pharmacology|October 26, 2016
Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and ClearanceHannah H Lee, Brenda F Leake, Richard B Kim, et al.
Pageof 23